These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 33377195)

  • 1. Performance and outcome of the subcutaneous implantable cardioverter-defibrillator after transvenous lead extraction.
    Chung DU; Tauber J; Kaiser L; Schlichting A; Pecha S; Sinning C; Rexha E; Reichenspurner H; Willems S; Gosau N; Hakmi S
    Pacing Clin Electrophysiol; 2021 Feb; 44(2):247-257. PubMed ID: 33377195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transvenous lead extraction of implantable cardioverter-defibrillators: A comprehensive outcome-and risk factor analysis.
    Chung DU; Burger H; Kaiser L; Osswald B; Bärsch V; Nägele H; Knaut M; Reichenspurner H; Gessler N; Willems S; Butter C; Pecha S; Hakmi S;
    Pacing Clin Electrophysiol; 2023 Aug; 46(8):815-823. PubMed ID: 37461858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use and outcomes of subcutaneous implantable cardioverter-defibrillator (ICD) after transvenous ICD extraction: An analysis of current clinical practice and a comparison with transvenous ICD reimplantation.
    Viani S; Migliore F; Tola G; Pisanò ECL; Russo AD; Luzzi G; Sartori P; Piro A; Rordorf R; Forleo GB; Rago A; Segreti L; Bertaglia E; Biffi M; Lovecchio M; Valsecchi S; Diemberger I; Bongiorni MG
    Heart Rhythm; 2019 Apr; 16(4):564-571. PubMed ID: 30366163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transvenous extraction of implantable cardioverter-defibrillator leads under advisory--a comparison of Riata, Sprint Fidelis, and non-recalled implantable cardioverter-defibrillator leads.
    Brunner MP; Cronin EM; Jacob J; Duarte VE; Tarakji KG; Martin DO; Callahan T; Borek PP; Cantillon DJ; Niebauer MJ; Saliba WI; Kanj M; Wazni O; Baranowski B; Wilkoff BL
    Heart Rhythm; 2013 Oct; 10(10):1444-50. PubMed ID: 23816440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subcutaneous implantable cardioverter defibrillator after transvenous lead extraction: safety, efficacy and outcome.
    Giacomin E; Falzone PV; Dall'Aglio PB; Pittorru R; De Lazzari M; Vianello R; Bertaglia E; Tarzia V; Iliceto S; Gerosa G; Migliore F
    J Interv Card Electrophysiol; 2022 Jul; ():. PubMed ID: 35831772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanical extraction of implantable cardioverter-defibrillator leads with a dwell time of more than 10 years: insights from a single high-volume centre.
    Ząbek A; Boczar K; Ulman M; Holcman K; Kostkiewicz M; Pfitzner R; Dębski M; Musiał R; Lelakowski J; Małecka B
    Europace; 2023 Mar; 25(3):1100-1109. PubMed ID: 36660771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extraction outcomes of implantable cardioverter-defibrillator leads vary by manufacturer and model family.
    Hayashi K; Callahan T; Rickard J; Younis A; Baranowski B; Martin D; Nakhla S; Tabaja C; Wilkoff BL
    Europace; 2023 Dec; 25(12):. PubMed ID: 38000893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of outcomes and required tools between transvenous extraction of pacemaker and implantable cardioverter defibrillator leads: Insight from single high-volume center experience.
    Hayashi K; Callahan T; Rickard J; Baranowski B; Martin DO; Nakhla S; Tabaja C; Paul A; Wilkoff BL
    J Cardiovasc Electrophysiol; 2024 Jul; 35(7):1382-1392. PubMed ID: 38725252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcutaneous Versus Transvenous Implantable Defibrillator Therapy: A Meta-Analysis of Case-Control Studies.
    Basu-Ray I; Liu J; Jia X; Gold M; Ellenbogen K; DiNicolantonio J; Komócsi A; Vorobcsuk A; Kim J; Afshar H; Lam W; Mathuria N; Razavi M; Rasekh A; Saeed M
    JACC Clin Electrophysiol; 2017 Dec; 3(13):1475-1483. PubMed ID: 29759827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Clinical Outcomes of Subcutaneous Versus Transvenous Implantable Defibrillator Therapy.
    Brouwer TF; Yilmaz D; Lindeboom R; Buiten MS; Olde Nordkamp LR; Schalij MJ; Wilde AA; van Erven L; Knops RE
    J Am Coll Cardiol; 2016 Nov; 68(19):2047-2055. PubMed ID: 27810043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Same-day discharge after transvenous lead extraction: feasibility and outcomes.
    Atteya G; Alston M; Sweat A; Saleh M; Beldner S; Mitra R; Willner J; John RM; Epstein LM
    Europace; 2023 Feb; 25(2):586-590. PubMed ID: 36575941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcutaneous versus transvenous implantable cardioverter defibrillators in children and young adults: A meta-analysis.
    Vetta G; Parlavecchio A; Magnocavallo M; Valente D; Caminiti R; Polselli M; Vetta F; Cirone D; Cauti FM; Crea P; Rossi P; Chierchia GB; Bianchi S; de Asmundis C; Natale A; Della Rocca DG
    Pacing Clin Electrophysiol; 2022 Dec; 45(12):1409-1414. PubMed ID: 36214206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infection and mortality after implantation of a subcutaneous ICD after transvenous ICD extraction.
    Boersma L; Burke MC; Neuzil P; Lambiase P; Friehling T; Theuns DA; Garcia F; Carter N; Stivland T; Weiss R;
    Heart Rhythm; 2016 Jan; 13(1):157-64. PubMed ID: 26341604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and safety of transvenous extraction of single- versus dual-coil implantable cardioverter-defibrillator leads at single-center experience.
    Ząbek A; Boczar K; Dębski M; Ulman M; Pfitzner R; Musiał R; Lelakowski J; Małecka B
    Medicine (Baltimore); 2019 Jul; 98(30):e16548. PubMed ID: 31348275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A propensity matched case-control study comparing efficacy, safety and costs of the subcutaneous vs. transvenous implantable cardioverter defibrillator.
    Honarbakhsh S; Providencia R; Srinivasan N; Ahsan S; Lowe M; Rowland E; Hunter RJ; Finlay M; Segal O; Earley MJ; Chow A; Schilling RJ; Lambiase PD
    Int J Cardiol; 2017 Feb; 228():280-285. PubMed ID: 27865198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk Factors and Long-Term Survival of Octogenarians and Nonagenarians Undergoing Transvenous Lead Extraction Procedures.
    Jacheć W; Polewczyk A; Segreti L; Bongiorni MG; Kutarski A
    Gerontology; 2021; 67(1):36-48. PubMed ID: 33242867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcutaneous Versus Transvenous Implantable Defibrillator Therapy: A Systematic Review and Meta-Analysis of Randomized Trials and Propensity Score-Matched Studies.
    Fong KY; Ng CJR; Wang Y; Yeo C; Tan VH
    J Am Heart Assoc; 2022 Jun; 11(11):e024756. PubMed ID: 35656975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical predictors of adverse patient outcomes in an experience of more than 5000 chronic endovascular pacemaker and defibrillator lead extractions.
    Brunner MP; Cronin EM; Duarte VE; Yu C; Tarakji KG; Martin DO; Callahan T; Cantillon DJ; Niebauer MJ; Saliba WI; Kanj M; Wazni O; Baranowski B; Wilkoff BL
    Heart Rhythm; 2014 May; 11(5):799-805. PubMed ID: 24444444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propensity score matched comparison of subcutaneous and transvenous implantable cardioverter-defibrillator therapy in the SIMPLE and EFFORTLESS studies.
    Brouwer TF; Knops RE; Kutyifa V; Barr C; Mondésert B; Boersma LVA; Lambiase PD; Wold N; Jones PW; Healey JS
    Europace; 2018 Sep; 20(FI2):f240-f248. PubMed ID: 29771327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Efficacy of Subcutaneous Cardioverter Defibrillator in Patients at High Risk of Sudden Cardiac Death　- Primary Japanese Experience.
    Sasaki S; Tomita H; Tsurugi T; Ishida Y; Shoji Y; Nishizaki K; Kinjo T; Endo T; Nishizaki F; Hanada K; Sasaki K; Horiuchi D; Kimura M; Higuma T; Okamatsu H; Tanaka Y; Koyama J; Okumura K
    Circ J; 2018 May; 82(6):1546-1551. PubMed ID: 29643282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.